30
Participants
Start Date
February 6, 2024
Primary Completion Date
May 3, 2026
Study Completion Date
May 3, 2026
Biopsy Procedure
Undergo tissue biopsy
Biospecimen Collection
Undergo blood and tissue sample collection
Computed Tomography
Undergo CT scan
Magnetic Resonance Imaging
Undergo MRI
Pegylated Liposomal Doxorubicin Hydrochloride
Given IV
Peposertib
Given PO
RECRUITING
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
RECRUITING
National Cancer Institute Developmental Therapeutics Clinic, Bethesda
RECRUITING
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
RECRUITING
University of Virginia Cancer Center, Charlottesville
RECRUITING
University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
SUSPENDED
University of Michigan Comprehensive Cancer Center, Ann Arbor
RECRUITING
UC Comprehensive Cancer Center at Silver Cross, New Lenox
RECRUITING
University of Chicago Medicine-Orland Park, Orland Park
RECRUITING
University of Chicago Comprehensive Cancer Center, Chicago
RECRUITING
Washington University School of Medicine, St Louis
RECRUITING
Siteman Cancer Center-South County, St Louis
RECRUITING
M D Anderson Cancer Center, Houston
RECRUITING
UCHealth University of Colorado Hospital, Aurora
RECRUITING
Los Angeles General Medical Center, Los Angeles
RECRUITING
USC / Norris Comprehensive Cancer Center, Los Angeles
RECRUITING
Dana-Farber Cancer Institute, Boston
National Cancer Institute (NCI)
NIH